Controlled-releasing hydrogen sulfide donor based on dual-modal iron oxide nanoparticles protects myocardial tissue from ischemia–reperfusion injury

BACKGROUND: Hydrogen sulfide (H(2)S) has shown promising therapeutic benefits in reversing a variety of pathophysiological processes in cardiovascular system, including myocardial ischemia–reperfusion (IR) injury. However, the achievement of controlled and sustained release of H(2)S has been a techn...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Wenshuo, Liu, Huan, Lu, Yuntao, Wang, Xiaole, Zhang, Bohan, Cong, Shuo, Zhao, Yun, Ji, Minbiao, Tao, Hongyue, Wei, Lai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6363493/
https://www.ncbi.nlm.nih.gov/pubmed/30787606
http://dx.doi.org/10.2147/IJN.S186225

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6363493/
https://www.ncbi.nlm.nih.gov/pubmed/30787606
http://dx.doi.org/10.2147/IJN.S186225

Ejemplares similares